UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER
Clinical trials for UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo may make inoperable lung cancer removable
Disease control Recruiting nowThis study tests whether giving a combination of drugs (IBI308, bevacizumab, pemetrexed, and carboplatin) before surgery can shrink stage III non-small cell lung cancer enough to allow surgical removal. The goal is to see how many people can then have surgery. The study includes …
Matched conditions: UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug combo aims to shrink lung tumors enough for surgery
Disease control Recruiting nowThis phase II trial tests whether a new drug called IBI363, combined with standard chemotherapy, can shrink stage III non-small cell lung cancer that was initially too advanced to remove with surgery. The goal is to make the tumors operable, then remove them. About 43 adults with…
Matched conditions: UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC